InsidersTradesSigma
Track the 인바이오 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Chemicals sector, 인바이오 has recorded 5 public disclosures. Market capitalisation: €21.7bn. The latest transaction was filed on 30 June 2026 (Purchase). Among the most active insiders: 이혁재. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Inbio es una empresa especializada en el sector de la química y los materiales, cotizada en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras en el campo de la biotecnología.